Delivery Order SPE2DX22D0010-SPE2D825FHE47
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $47,608.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp is a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,840.50 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with ultimate completion by July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,239.24 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,567.40 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $29,247.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999.9 million through December 2026. The award was competitively...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,449.06 to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to the Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp serves as a critical vendor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,274.68 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,263.40 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made through competitive procedures with no set-aside...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHE47Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $29,601.60 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order represents a non-competitive award to the established pharmaceutical distributor and is performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. Through this flexible contracting mechanism, AmerisourceBergen Drug Corp serves customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key participant in the DLA's pharmaceutical supply network for defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.6k | 7/25/25 |